compounds, pharmaceutical composition and methods for the treatment of a neoplastic disease, for the treatment of an inflammatory or autoimmune disorder, for the treatment of a neurodegenerative disease and for the treatment of a metabolic disorder
The present invention relates to novel compounds with low cytotoxicity for blocking the ubiquitination proteasome system in diseases. Accordingly, these compounds may be used in the treatment of treatment disorders including but not limited to cancers, neurodegenerative disorders, inflammatory diseases and autoimmune disorders and metabolic disorders.a presente invenção se refere aos novos compostos com baixa citotoxicidade para o bloqueio do sistema de proteassoma de ubiquitinação em doenças. consequentemente, estes compostos podem ser utilizados no tratamento de distúrbios de tratamento incluindo, mas não limitados aos cânceres, doenças neurodegenerativas, doenças inflamatórias e distúrbios autoimunes e distúrbios metabólicos.
